September 3, 2025 — Leads & Copy — ImmunoPrecise Antibodies Ltd. is now MindWalk, unifying its subsidiaries BioStrand and Talem under a single corporate brand. The company’s Nasdaq ticker symbol will change to HYFT.
According to MindWalk, the new identity reflects its evolution into a Bio-Native AI platform business that converges AI, multi-omics data, and advanced laboratory research.
Dr. Jennifer Bath, President and Chief Executive Officer of MindWalk, stated that this rebranding marks an evolutionary step forward, converting biological insights into impactful medicines by uniting science, computation, and responsible experimentation.
MindWalk operates as a Bio-Native AI company, integrating data across formats and disciplines to transform information into biological meaning. The company’s LensAI™ platform, powered by HYFT® technology, aims to redefine how biologics are discovered and developed.
The transition includes a shift from standalone wet-lab services to an integrated platform company model, launching DaaS and SaaS offerings, enhancing asset generation, and enabling large-scale partnerships.
For more information, visit mindwalkAI.com.
Contact:
Dr. Jennifer Bath
President and Chief Executive Officer
